Change in obsessive beliefs as predictor and mediator of symptom change during treatment of obsessive-compulsive disorder – a process-outcome study by unknown
RESEARCH ARTICLE Open Access
Change in obsessive beliefs as predictor
and mediator of symptom change during
treatment of obsessive-compulsive
disorder – a process-outcome study
Alice Diedrich1*, Philipp Sckopke2, Caroline Schwartz1, Sandra Schlegl1, Bernhard Osen3, Christian Stierle3
and Ulrich Voderholzer4,5
Abstract
Background: Cognitive models of obsessive-compulsive disorder suggest that changes in obsessive beliefs are a
key mechanism of treatments for obsessive-compulsive disorder. Thus, in the present process-outcome study, we
tested whether changes in obsessive beliefs during a primarily cognitive behavioral inpatient treatment predicted
treatment outcome and whether these changes mediated symptom changes over the course of treatment.
Methods: Seventy-one consecutively admitted inpatients with obsessive-compulsive disorder were assessed with
the Yale-Brown Obsessive-Compulsive Scale and the Obsessive Beliefs Questionnaire at treatment intake, after six
weeks of treatment and at discharge, and with the Beck-Depression-Inventory-II at intake and discharge.
Results: Changes in obsessive beliefs during the first six weeks of treatment predicted obsessive-compulsive
symptoms at discharge when controlling for obsessive-compulsive and depressive symptoms at intake in a
hierarchical regression analysis. Multilevel mediation analyses showed that reductions in obsessive beliefs
partially mediated improvements in obsessive-compulsive symptoms over time.
Conclusions: Our findings indicate that decreasing obsessive beliefs in inpatient cognitive behavioral therapy
for obsessive-compulsive disorder might be a promising treatment approach.
Keywords: Obsessive-compulsive disorder, Inpatient treatment, Cognitive behavioral therapy, Obsessive beliefs,
Mediator, Change mechanism
Background
Obsessive-compulsive disorder (OCD) is characterized
by a pattern of repetitive obsessive thoughts, images, or
impulses and a ritualized pattern of covert mental acts
or overt behaviors, aimed at reducing associated negative
emotions, including anxiety and fear [1]. According to
the International Classification of Diseases-10 (ICD-10),
three OCD subtypes exist: one with predominantly ob-
sessional thoughts and ruminations, one with predomi-
nantly compulsive acts, and one with mixed obsessional
thoughts and acts. OCD is a significant, often chronic
[2, 3] and highly comorbid [4] mental health problem.
Moreover, it is associated with a reduced quality of life
[5], functional impairment [5], and anguish for patients
and their families [6]. As such, it constitutes the 10th
leading cause of disability among health conditions [7].
Cognitive behavioral therapy (CBT) including exposure
and response prevention (ERP) as well as the modification
of dysfunctional beliefs about the meaning and significance
of obsessive thoughts has been recommended as the treat-
ment of choice in treatment guidelines [8–10] – either
alone or in combination with selective serotonin reuptake
inhibitors. Several treatment outcome studies have estab-
lished the (long-term) effectiveness of (C)BT and selective
serotonin reuptake inhibitors in both out- and inpatient
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settings [11–18]. However, prior research also shows that
OCD symptoms persist at moderate levels even after an ad-
equate treatment course [3, 11], and some studies indicate
that about 30 to 50 % of patients do not benefit from CBT
in terms of symptom reduction [11, 19, 20]. Thus, current
treatments still need to be further improved. One way to
reach this goal is to identify central predictors and mediators
of symptom reductions during treatment for OCD [21, 22].
Cognitive behavioral models of OCD emphasize the
role of dysfunctional beliefs in the development and
maintenance of OCD (see for example, [23–25]). Specif-
ically, they postulate that obsessive beliefs contribute to
negative appraisals of intrusive thoughts, i.e. obsessional
thoughts, which may then cause compulsive behavior to
reduce associated negative emotions. Hence, obsessive
beliefs can be considered as predisposing factors of ob-
sessional thoughts and compulsive acts. A number of
cognitive models of OCD exist and each of those models
focuses on a different belief domain regarding the eti-
ology and maintenance of the disorder [23, 24, 26]. Con-
sistently, the Obsessive Compulsive Cognitions Working
Group (OCCWG) [27, 28] identified the following dys-
functional belief domains to be important in this con-
text: inflated sense of personal responsibility, need for
certainty, perfectionism, threat estimation, importance
of thoughts, and need to control thoughts. Preliminary
evidence for the significance of dysfunctional beliefs as a
risk and maintaining factor in OCD comes from studies
demonstrating positive cross-sectional associations be-
tween obsessive beliefs and obsessive-compulsive symp-
tom severity both in non-clinical samples [29, 30] and
samples with individuals suffering from OCD [31–34].
Based on this theoretical and empirical background, it
might be assumed that the extent of obsessive beliefs at
the beginning of treatment impacts treatment outcome.
Moreover, it might be hypothesized that changes over
the course of treatment predict treatment outcome or
even constitute an important mechanism of treatment in
OCD. Preliminary evidence for these hypotheses comes
from treatment studies indicating that symptom changes
during psychotherapy and/or medical treatment are either
predicted by the extent of obsessive beliefs at the begin-
ning of treatment [35, 36] or associated with changes in
obsessive beliefs during treatment [14, 35, 37–40]. Only
one study so far has yielded evidence that changes in mal-
adaptive beliefs precede changes in obsessive-compulsive
symptoms during an outpatient cognitive therapy [41].
However, until now, it has never been examined whether
treatment-associated changes in obsessive beliefs predict
and explain changes in obsessive-compulsive symptoms
during an intensive primarily cognitive behavioral in-
patient treatment. Therefore, the first aim of the present
study was to examine whether changes in obsessive beliefs
during the first six weeks of treatment predict treatment
outcome in patients suffering from severe OCD. The
second aim was to examine the mediating effect of
changes in obsessive beliefs on symptom changes during
treatment to test whether changes in obsessive beliefs
cause changes in treatment outcome.
Methods
Participants and design
The present study was part of another study examining
common factors of inpatient psychotherapy of patients
suffering from OCD in an uncontrolled repeated mea-
sures design (in preparation). One hundred fifty six pa-
tients who received an inpatient treatment during
January 2011 and May 2013 in two medical centers in
Germany were included in the study. To be included,
the participants were required to meet the criteria of an
obsessive-compulsive disorder according to the Diag-
nostic and Statistical Manual of Mental Disorders-IV
(DSM-IV), to be fluent in German, and to be between
18 and 65 years of age. Participants were excluded if
they had a high risk of suicide, an organic brain disorder,
or a severe medical condition. To enhance the external
validity of the study, we included patients who met cri-
teria for comorbid disorders in addition to OCD, with
the exception of patients with a current diagnosis of sub-
stance abuse or dependence, psychotic disorder or bipo-
lar disorder. From the initial sample of 156 individuals,
42 participants were not included in the analyses as they
were study or treatment drop-outs with missing data.
Another 43 patients were excluded due to missing data
without having dropped out from study or treatment.
Thus, our final sample consisted of N = 71 individuals
(for patient flow, see Fig. 1; for characteristics of the final
sample, see Table 1).
Patients from the initial and the final sample did not
differ significantly in terms of demographic (gender, age,
education), clinical (type OCD, comorbidities, severity of
obsessive-compulsive and depressive symptoms, extent
of obsessive beliefs) or treatment-specific (duration, anti-
depressive medication) variables (all ps > .05) except for
relationship (χ2(1) = 4.32, p = .04). Individuals who were
excluded from the study were more likely to be in a rela-
tionship than those who were included in the final sample.
Procedures
At admission to the hospital, an overall diagnostic assess-
ment according to the criteria of ICD-10 was administered
by clinical psychologists or psychiatrists for treatment pur-
poses. For research purposes, DSM-IV diagnoses of OCD
were also entered using the German version of the Struc-
tural Clinical Interview for DSM-IV [42]. It was conducted
by clinical psychologists who had at least a Master’s
degree and were enrolled in a PhD-program. The diag-
nostic assessments were thoroughly discussed with an
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experienced supervisor (as they were therapists in clinical
training). Patients were assessed with the Yale-Brown
Obsessive Compulsive Scale (Y-BOCS) [43] and the
Obsessive Beliefs Questionnaire (OBQ) [44] at intake,
after six weeks of treatment and at discharge, and with
the Beck Depression Inventory-II (BDI-II) [45] at treat-
ment intake and discharge. Means and standard devia-
tions of the measures are provided in Table 2.
Treatment
Patients received a multimodal, intensive inpatient treat-
ment program including both individual and group psy-
chotherapy. Individual therapy took place once or twice
a week for 50 min. Group therapies included occupa-
tional therapy, music therapy, sports therapy, and a
disorder-specific group. Individual therapy and the
disorder-specific group were both based on the cognitive
behavioral model. They included the following elements:
psycho-education about OCD symptoms and the CBT
rationale, individualized case formulation (including the
identification of potential functions of the symptoms), in
vivo ERP and the modification of interpretations of ob-
sessive thoughts as well as of obsessive beliefs. How-
ever, the focus of the treatment lay on ERP - both
therapist-guided and alone. Treatments were applied by
clinical psychologists and/or psychiatrists who were all
trained in CBT and supervised by experienced thera-
pists. Most patients (84.5 %) took antidepressants dur-
ing treatment. Mean treatment duration was 65.41 days
(SD = 24.15). Almost all patients of the final sample
(97.2 %) were discharged regularly.
Measures
Yale-Brown Obsessive Compulsive Scale
The German version of the Y-BOCS [43, 46] was used
to measure the severity of OCD symptoms. In the
present study, we utilized the clinician-administered
semi-structured interview of the Y-BOCS at admission
and discharge, and the self-report version after six
weeks of treatment. Both versions were found to be
interchangeable in a German sample [47]. The Y-BOCS
is a 10-item-measure with five items designed to assess
obsessional thoughts and five to assess compulsive be-
havior. Items are to be rated on a 5-point-scale ranging
from 0 (no symptoms) to 4 (extreme symptoms). The
German version of the Y-BOCS has shown good to very
good inter-rater reliabilities, good internal consistency
Initial sample size: n = 156 
Dropouts (with missing data): n = 42 (26.9%) 
  
From study: n = 17 (10.9 %) 
Lack of energy (n = 16) 
Unsatisfied with study (n = 1) 
From treatment and study: n = 25 (16.0 %) 
Premature departure (n = 25) 
n = 114 (73.1 %) 
Excluded from analyses due to missing data in any 
measure used and at any measuring point: n = 43 
(37.7 %) 
OBQ – pre: n = 1 
Y-BOCS – pre: n = 13 
BDI-II – pre: n = 18 
OBQ – after 6 weeks of treatment: n = 17 
Y-BOCS – after 6 weeks of treatment: n = 17 
OBQ – post: n = 8 
Y-BOCS – post: n = 11 
BDI-II – post: n = 21 
Final sample size: n = 71 (62.3 %) 
Regular discharges: n = 69 (97.2 %) Premature discharges: n = 2 (2.8 %) 
Fig. 1 Flow chart of the sample. The described percentages refer
to the sample size reported before
Table 1 Sample characteristics
M (SD)/% (N) % (N)
Female gender 59.2 (42) Comorbid mental disorders 83.1 (59)
Age (years) 34.59 (11.20) Depressive disorders 77.5 (55)
High school degree 56.3 (40) Dysthymic disorder 2.8 (2)
In a relationship 38.0 (27) Anxiety disorders 18.3 (13)
OCD subtypes Adjustment disorder 2.8 (2)
F42.0 4.2 (3) Somatoform disorders 4.2 (3)
F42.1 5.6 (4) Eating disorders 8.5 (6)
F42.2 90.1 (64) Personality disorders 9.9 (7)
Note. N = 71. OCD =Obsessive-Compulsive Disorder. F42.0 = Predominantly obsessional thoughts and ruminations, F42.1 = Predominantly compulsive acts, F42.2 =
Mixed obsessional thoughts and acts. Anxiety disorders comprise panic disorder, generalized anxiety disorder, phobic disorder and posttraumatic stress
disorder. As all participants were Caucasians we do not report differences with regard to ethnicity. High School = German equivalent of high school certificate
after 13 years of schooling
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[48], and good convergent validity when compared to
the Obsessive-Compulsive Inventory-Revised [49]. In
the present study, the Y-BOCS displays good to excel-
lent internal consistencies at all three assessment
points (Cronbach’s α = .79 - .93).
Beck Depression Inventory-II
The BDI-II [45] is a widely used self-report question-
naire to measure depressive symptomatology within the
last two weeks. The questionnaire consists of 21 items.
For every item, participants have to choose one state-
ment with an assigned value between 0 and 3. We used
the German translation which exhibits satisfactory in-
ternal consistency, acceptable test-retest reliability, good
convergent, discriminant and factorial validity, as well as
good sensitivity to change [50–52]. Consistent with the
findings by Hautzinger and colleagues [50], the internal
consistencies in the present study varied from good to
excellent at treatment intake and discharge (Cronbach’s
α = .88 - .93).
Obsessive Beliefs Questionnaire
The OBQ [44] is a 44-item questionnaire designed to
measure the key belief domains of OCD identified by
the OCCWG. It consists of three factor-analytically de-
rived subscales: (1) responsibility and threat estimation;
(2) perfectionism and intolerance for uncertainty; (3)
importance and control of thoughts (metacognitions).
Answers are rated on a 7-point-scale (1 = “disagree very
much” to 7 = “agree very much”) [44]. In the present
study, we used the abbreviated German adaptation of
the OBQ [53]. Factor analyses of the translated English
version resulted in one version with only twenty-four
items loading on the same factors as the English version.
All scales of the German version of the OBQ exhibit
good internal consistencies, acceptable retest reliabilities,
and satisfactory convergent and discriminant construct
validity as well as criterion validity [53]. As such, the
psychometric quality of the German adaptation of the
OBQ is comparable to the English original [53]. Consis-
tent with the findings by Ertle and colleagues [53], the
internal consistencies of the OBQ found in the present
study varied from good to excellent at the three assess-
ment points (Cronbach’s α = .92 - .93).
Data analyses
To evaluate whether changes in obsessive beliefs during
the first six weeks of treatment predict symptoms at dis-
charge we conducted a hierarchical regression analysis.
We entered obsessive-compulsive symptoms at intake of
treatment in the first step and depressive symptoms at
admission in the second step to control for potential
confounding effects. Changes in obsessive beliefs be-
tween intake and six weeks of treatment were entered in
the third step. To identify which specific obsessive belief
domain best predicts treatment outcome, we conducted
another hierarchical regression analysis. In this one, we
also controlled for obsessive-compulsive and depressive
symptom severity at intake (step 1 and 2) but entered
changes in the three domains of the OBQ as predictors
instead of the global score (step 3). We used SPSS ver-
sion 23 for these analyses.
To examine whether changes in obsessive beliefs medi-
ate changes in obsessive-compulsive symptoms, we used
the procedure originally proposed by Baron and Kenny
[54] and applied it to a multilevel framework as recently
suggested [55]. For these analyses, we used the software R
[56] with packages lme4 [57] and lmerTest [58]. The lon-
gitudinal nature of our design produced a multilevel data
structure [55, 59], in which the lower level, or Level 1 data
(i.e. the repeated measures of both obsessive-compulsive
symptoms and obsessive beliefs), were nested within
upper level, or Level 2, units (i.e. the participants). This
data structure is appropriate for contemporary growth
curve modeling techniques [60]. Given that pre-scores
varied between the individuals, we examined this change
over time in a multilevel random coefficient regression
framework [61, 62]. According to the approach by Kenny,
Korchmaros, & Bolger [63], mediation can be established
if the following four statistical criteria are met: (1) Pre-
dictor and mediator are significantly related (path a), (2)
predictor and criterion are significantly correlated (path c),
(3) mediator and criterion are significantly related when
the predictor is controlled for (path b), and (4) the rela-
tionship between predictor and criterion is smaller when
the mediator is controlled for (path c’) compared to when
it is not (path c). To examine whether obsessive beliefs
mediate symptom changes, we tested a lower level
mediation model [63], in which time (intake, after six
weeks of treatment, discharge) was the predictor variable,
obsessive-compulsive symptom severity the criterion, and
obsessive beliefs the mediator. To control for potential
Table 2 Descriptive statistics for measurements at T1, T2, and T3
T1 T2 T3
M SD M SD M SD
Y-BOCS 24.82 5.96 19.82 7.37 16.99 7.50
OBQ - Global 4.41 1.17 4.15 1.17 3.80 1.12
OBQ-RES 4.78 1.69 4.55 1.61 4.25 1.59
OBQ-PER 4.87 1.34 4.66 1.30 4.24 1.20
OBQ-IMP 3.37 1.62 3.04 1.54 2.60 1.26
BDI-II 21.76 10.47 14.35 11.47
Note. N = 71. T1 = intake, T2 = after six weeks of treatment, T3 = discharge.
Y-BOCS = Yale-Brown Obsessive Compulsive Scale. OBQ - Global = Obsessive
Beliefs Questionnaire Global Score. RES = responsibility and threat estimation.
PER = perfectionism and intolerance for uncertainty. IMP = importance and
control of thoughts (metacognitions). BDI-II = Beck Depression Inventory-II
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confounding effects of changes in depressive symptom
severity during treatment, we included changes in de-
pressive symptoms during treatment as another pre-
dictor in each of the three regression analyses. The
decision to control for (changes in) depressive symptom
severity in our analyses was based on the high rate of
depressive disorders in the sample of the present study.
Moreover, it was based on prior research indicating
confounding effects of (changes in) depressive symp-
toms both on treatment outcome [37, 64] as well as on
the relation between changes in obsessive beliefs and
obsessive-compulsive symptoms post-treatment [65].
Further potentially confounding variables such as gen-
der, age, treatment duration, anti-depressive medication
and comorbidities were neither related to (changes in)
obsessive-compulsive symptoms nor to changes in
obsessive beliefs (all ps > .05). Thus, we did not enter
them as further covariates in our analyses. However, as
individual means of the mediator may alter the estima-
tion of paths in a multilevel framework [66], we in-
cluded values of the mediator that were centered on
the individual mean (group-mean centering) as well.
We used Sobel’s test [67] to test the significance of the
indirect effect of the hypothesized mediation model
(i.e., the product of the regression weights from paths a
and b). The test has already been discussed in a multi-
level framework by Krull and MacKinnon [68]. For all
our analyses, we set alpha at p < .05.
Results
Regression analyses
Results of the first hierarchical regression analysis are
presented in Table 3. They indicate that - when con-
trolling for obsessive compulsive symptom severity
(β = .49, t = 4.77, p < .001) and depressive symptom
load (β = .07, t = 0.73, p = .47) at intake - changes of
obsessive beliefs (global score) between intake and
after six weeks of treatment significantly predicted
obsessive-compulsive symptoms at discharge (β = -.24,
t = -2.38, p = .02) and explained 6 % of the outcome
variance (ΔF(1,67) = 5.64, p = .02).
As indicated in Table 4, the second hierarchical regres-
sion analysis showed that after controlling for variance
explained by obsessive-compulsive and depressive symp-
tom load at intake, entering all three belief domains in
the next regression step revealed a clear tendency towards
significance for the prediction of obsessive-compulsive
symptoms at discharge (ΔF(3,65) = 2.68, p = .05). All
three belief domains together accounted for 8 % of the
variance of outcome. Findings also indicated a trend
for the domain “importance and control of thoughts”
to independently predict treatment outcome (β = -.20,
t = -1.74, p = .09).
Mediation analyses
Table 5 and Fig. 2 both show the results of the medi-
ation analyses. When time was entered into the Level 1
regression equation predicting obsessive-compulsive
symptom severity (path c) while controlling for changes
in depressive symptom load between treatment intake
and discharge, the regression coefficient indicated that
obsessive-compulsive symptoms decreased significantly
over the course of treatment (B = -3.92, p < .001). When
time was entered into the Level 1 regression equation
predicting obsessive beliefs (path a) while controlling for
depressive symptom change, the regression coefficient
showed that obsessive beliefs decreased significantly over
time as well (B = -0.32, p < .001). When both time and
depressive symptom change were controlled for, the re-
gression coefficient showed that obsessive beliefs signifi-
cantly predicted obsessive-compulsive symptoms (path
b; B = 1.77, p = .001). This indicates that participants
who showed fewer obsessive beliefs also suffered from a
lower degree of obsessive-compulsive symptoms. Finally,
when controlling for both obsessive beliefs and de-
pressive symptom change, time still significantly pre-
dicted obsessive-compulsive symptoms (path c‘; B = -3.35,
p < .001), but the regression coefficient was smaller than
Table 3 Regression analysis with obsessive-compulsive symptoms (T3) as outcome and obsessive belief-changes (ΔT1-T2) as predictor
ΔR2 ΔF p B SE B β t p
Step 1 .27 26.03 < .001
Y-BOCS T1 0.66 0.13 .52 5.10 < .001
Step 2 .01 0.71 .40
Y-BOCS T1 0.63 0.13 .50 4.77 < .001
BDI-II T1 0.06 0.08 .09 0.85 .40
Step 3 .06 5.64 .02
Y-BOCS T1 0.61 0.13 .49 4.77 < .001
BDI-II T1 0.05 0.07 .07 0.73 .47
OBQ-Global ΔT1-T2 -1.89 0.80 -.24 -2.38 .02
Note. N = 71. Obsessive-compulsive and depressive symptoms (T1) were entered as covariates. T1 = intake, T2 = after six weeks of treatment, T3 = discharge.
Y-BOCS = Yale-Brown Obsessive Compulsive Scale. OBQ-Global = Obsessive Beliefs Questionnaire Global Score. BDI-II = Beck Depression Inventory-II
Diedrich et al. BMC Psychiatry  (2016) 16:220 Page 5 of 10
the one of path c. This is an indicator of a partial medi-
ation. Sobel’s test of the indirect effect of time on
obsessive-compulsive symptoms via obsessive beliefs
was significant (ab = -0.57, z = -3.03, p = .002). Thus, all
criteria for a partial mediation are met. This indicates
that changes in obsessive-compulsive symptoms may be
explained by changes in obsessive beliefs during in-
patient treatment.
To examine whether treatment-associated changes in
obsessive beliefs result both in changes in obsessions
and compulsions, we computed two exploratory post-
hoc mediational models: one with obsession severity
as criterion and another one with compulsion severity
as criterion while controlling for depressive symptom
changes. Results show that changes in obsessive beliefs
partially mediate the association between time and ob-
sessions (b: B = 1.08, p < .001; c: B = -1.85, p < .001; c’:
B = -1.51, p < .001; ab = -0.35, z = -3.19, p = .001), and
between time and compulsions (b: B = 0.86, p = .008;
c: B = -1.94, p < .001; c’: B = -1.66, p < .001; ab = -0.28,
z = -2.55, p = .01). A comparison of the regression co-
efficients of the indirect effect of both models indi-
cates that changes in obsessive beliefs explain changes
in obsessions and compulsions to a similar extent.
However, these findings should not be over-interpreted
due to multiple testing and a potential alpha-error-
accumulation.
Discussion
The present study showed that changes in global obses-
sive beliefs during the first part of an intensive, primarily
cognitive behavioral inpatient treatment for individuals
with severe OCD predict treatment outcome. Further
on, it offered preliminary evidence that changes in be-
liefs regarding the importance of thoughts and the need
to control thoughts are most important in predicting
treatment outcome when considering the belief domains
identified by the OCCWG [27, 28]. Finally, it pointed
out that changes in obsessive beliefs partially explain pa-
tients’ improvements during treatment and may thus
constitute an essential change mechanism in intensive
cognitive behavioral inpatient treatment for OCD.
Our findings are consistent with the large body of evi-
dence demonstrating positive cross-sectional associa-
tions between obsessive beliefs and obsessive-compulsive
symptom severity [31–34]. Moreover, they add to the
findings that symptom changes during cognitive, be-
havioral and cognitive behavioral treatments are either
predicted by the extent of obsessive beliefs at the be-
ginning of treatment [35, 36] or even associated with
[14, 35, 37–39] or predicted by [41] changes in obsessive
beliefs during treatment. The finding that changes in ob-
sessive beliefs partially mediated symptom changes is
consistent with results showing that emotion activation
and habituation explain symptom changes during CBT as
Table 4 Multiple regression with obsessive-compulsive symptoms (T3) as outcome and belief domain-changes (ΔT1-T2) as predictors
ΔR ΔF p B SE B β t p
Step 1 .27 26.03 < .001
Y-BOCS T1 0.66 0.13 .52 5.10 < .001
Step 2 .01 0.71 .40
Y-BOCS T1 0.63 0.13 .50 4.77 < .001
BDI-II T1 0.06 0.08 .09 0.85 .40
Step 3 .08 2.68 .05
Y-BOCS T1 0.60 0.13 .48 4.46 < .001
BDI-II T1 0.08 0.08 .11 1.03 .31
OBQ-RES ΔT1-T2 0.34 0.68 .06 0.50 .62
OBQ-PER ΔT1-T2 -1.18 0.86 -.17 -1.37 .18
OBQ-IMP ΔT1-T2 -1.16 0.67 -.20 -1.74 .09
Note. N = 71. Obsessive-compulsive and depressive symptoms (T1) were entered as covariates. T1 = intake, T2 = after six weeks of treatment, T3 = discharge.
Y-BOCS = Yale-Brown Obsessive Compulsive Scale. OBQ = Obsessive Beliefs Questionnaire. RES = responsibility and threat estimation. PER = perfectionism and
intolerance for uncertainty. IMP = importance and control of thoughts (metacognitions). BDI-II = Beck Depression Inventory-II
Table 5 Regression analyses for the hypothesized mediation model with obsessive beliefs as mediator
Step Path Predictor variable Outcome variable B SE B t p
1 c Time Y-BOCS -3.92 0.38 -10.41 < .001
2 a Time OBQ - Global -0.32 0.05 -6.94 < .001
3 b OBQ - Global Y-BOCS 1.77 0.54 3.27 .001
c' Time Y-BOCS -3.35 0.40 -8.29 < .001
Note. N = 71. Y-BOCS = Yale-Brown Obsessive Compulsive Scale. OBQ - Global = Obsessive Beliefs Questionnaire Global Score
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well [69–71]. The non-significant trend of changes in
metacognitions as a predictor of outcome is consistent
with previous research showing that changes in metacog-
nitions is the only obsessive belief domain that is associ-
ated with symptom changes during (C)BT [35, 41, 65].
Finally, our findings extend previous research as they
show that changes in obsessive beliefs during an intensive
inpatient CBT predict symptom changes longitudinally
and even explain treatment success.
Thus, from a theoretical perspective, our results add
weight to cognitive and meta-cognitive models of OCD
that emphasize the role of dysfunctional (meta-cognitive)
beliefs in the development and maintenance of OCD
(see for example, [23–26]) and suggest that reductions
in (metacognitive) obsessive beliefs lead to reductions in
obsessive symptom severity. From a clinical perspective,
they indicate that changes in obsessive beliefs are one of
the working mechanisms of inpatient CBT in OCD.
Thus, focusing more strongly on changing obsessive be-
liefs in CBT for OCD seems to be a promising treatment
approach, especially as the extent of changes in obsessive
beliefs in the present study was rather small; with a
greater focus on obsessive beliefs, even greater symptom
changes might be achieved.
Unfortunately, prior research does not unambiguously
show which treatment is best suited to foster changes in
obsessive beliefs. While it is clear that both CBT and ERP
and cognitive therapy alone have the potential to decrease
obsessive beliefs [14, 37, 72–74], findings regarding a po-
tential superiority of either ERP or CT in changing dys-
functional beliefs are inconclusive. Whereas two studies
show that ERP is sufficient to produce strong improve-
ments in both obsessive-compulsive behavior and cogni-
tions [36, 72], another study indicates that ERP is more
effective if it is configured as a behavioral experiment
rather than when it is accompanied by a habituation ra-
tionale [75]. Thus, at this point in time, it seems to be best
practice to combine behavioral and cognitive elements in
inpatient treatment for OCD (to enhance changes in ob-
sessive beliefs) as recommended by current practice guide-
lines [8–10]. However, findings from the present study
suggest focusing on potential changes in (metacognitive)
obsessive beliefs in ERP debriefing to use the advantages
of both behavioral and cognitive interventions.
Strengths of the present study consist in including a
comparatively large number of inpatients with a validated
diagnosis of OCD and in assessing obsessive-compulsive
symptoms as well as obsessive beliefs at multiple assess-
ment points. Limitations of the present study include the
inpatient setting of the study and the lack of subgroup
analyses for several OCD subtypes due to the limited
sample size. The evaluation of a multimodal inpatient
treatment concept without a waiting control group nei-
ther allows us to unambiguously conclude that symptom
changes over time are due to treatment at all nor due to a
specific treatment element. More specifically, our study
does not provide any information about the exact effect
of each treatment element on changes both in obsessive
beliefs and obsessive-compulsive symptoms. Given that
treatment consisted of both a disorder-specific individual
and group therapy, and of a variety of additional therapies
(occupational therapy, music therapy, sports therapy), we
cannot specify which element is (most) responsible for
changes in obsessive beliefs and obsessive-compulsive
symptoms. Finally, our sample size precluded us from
conducting analyses in OCD subgroups. This is unfortu-
nate as specific dimensions of obsessive beliefs seem to be
associated with specific types of OCD (e.g., elevated re-
sponsibility and threat estimation in the washing-/check-
ing-subtype, elevated importance and control of thoughts
in the checking-subtype, elevated perfectionism and un-
certainty in the symmetry and ordering subtype; [31–34]).
It might be that dimensions of obsessive beliefs that
change during treatment (for example metacognitions)
depend on the subtype of OCD the patients suffer from.
Future research should address these questions in con-
trolled studies with larger sample sizes as these findings
could have important implications for understanding
variability in treatment response [76] and thus for im-
proving treatment outcome. Given the multimodal treat-
ment concept of the present study, future studies should
assess and examine the specific contribution of stand-
alone treatment elements in inpatient treatments on
changes in obsessive beliefs and obsessive-compulsive
symptoms. Moreover, future research should focus on
investigating specific change mechanisms (i.e. habitu-
ation and changes in obsessive beliefs) in ERP and cogni-
tive therapy in inpatient settings so that mediating
effects can unambiguously be attributed to a specific
Obsessive beliefs 







Time of measurement OCD symptoms 
c  
-3.92*** 
Fig. 2 Mediation model with obsessive beliefs as mediator between
time of measurement and obsessive-compulsive symptoms. N = 71.
The unstandardized regression coefficients are presented. *p < .05,
**p < .01, ***p < .001
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treatment. Finally, future research should test whether
(meta-)cognitive therapy enhances treatment outcome
and thus is indicated in specific individuals and situations,
for example in non-responders to behavioral therapy [77],
in patients who primarily suffer from obsessive thoughts
[78] or from strong belief distortions [79], and/or in pa-
tients with a strong aversion to exposure therapy [79].
Conclusions
Changes in obsessive beliefs are one of the working mech-
anisms of multimodal, but primarily cognitive behavioral
inpatient treatment in OCD. Thus, focusing more strongly
on changing obsessive beliefs in (inpatient) CBT for OCD
seems to be a promising treatment approach that might
help further improve current treatments for individuals
with OCD. Finally, it might represent an alternative treat-
ment approach for non-responder to behavioral interven-
tions and for those who suffer from strong cognitive
biases or who reject exposure-based interventions.
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